Best practices in the application of parallelism for biomarker assay validation
View abstract on PubMed
Summary
This summary is machine-generated.Parallelism assessment in biomarker assays ensures accurate measurement of endogenous analytes. This paper details best practices for conducting and interpreting parallelism experiments for reliable assay validation.
Area Of Science
- Biomarker assay development
- Analytical chemistry
- Clinical diagnostics
Background
- Parallelism is crucial for validating biomarker assays, ensuring endogenous analyte recognition mirrors calibrator behavior.
- Existing literature lacks detailed guidance on conducting and interpreting parallelism experiments, leading to confusion with similar assays like dilution linearity and spike recovery.
Purpose Of The Study
- To provide comprehensive best-practice guidelines for parallelism assessment in biomarker assays.
- To clarify the distinction between parallelism, dilution linearity, and spike recovery experiments.
- To ensure reliable analyte measurement within the intended context of use.
Main Methods
- Detailed discussion on the rationale for parallelism assessment.
- Recommendations for experimental design, including sample size and surrogate matrix selection.
- Guidance on interpreting parallelism data using graphical and statistical methods.
Main Results
- Established clear criteria for conducting and interpreting parallelism experiments.
- Highlighted the importance of continuous parallelism evaluation throughout the assay lifecycle.
- Provided case studies illustrating practical application and interpretation of parallelism data.
Conclusions
- Standardized parallelism assessment is essential for biomarker assay reliability.
- Adherence to best practices ensures accurate measurement of endogenous analytes.
- Continuous monitoring of parallelism guarantees assay performance over time.

